Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry.

RMD Open · 2026 · PMC13185012 · PMID 42150842

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep=0.10so close (0.05 < p ≤ 0.1)

A similar trend was suggested for JAK inhibitors, although it did not reach statistical significance (p=0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.